baber/WOPTO huggingface dataset:
Patent ES-513664-A0 (ES)
IPC: A61K9/10
Filed: 1982-07-02
Abstract: The invention relates to compositions in the form of a stable "fatty-cream" for topical application to the body which comprise a fatty base, water, at least one hydrophilic non-ionic surfactant and a topically-active therapeutic agent, the composition containing from 50 to 80% (preferably 60-70%) by weight of fatty material(s) and from 1.5 to 5% by weight of surfactant.
Patent ES-517378-A0 (ES)
IPC: B29D7/01
Filed: 1982-11-15
Abstract: The film (11) extruded from a vinylidene fluoride polymer is subjected to a stretching of at least 200% while still in the molten state, and then cooled rapidly to a temperature below 50 DEG  C. The equipment comprises, in series, an extruding device (1) (2), a cooling device consisting of a thermostatically controlled liquid bath (6), the level of which is located at a distance of 10 to 300 mm from the extruding device, and a device (8) (9) for stretching the extruded film by at least 200% in its part located between the extruding device and the cooling device. The film obtained is suitable for manufacturing piezoelectric films.
Patent ES-540550-A0 (ES)
IPC: H01R13/193
Filed: 1985-02-20
Abstract: A zero insertion force card edge connector (10) incorporates a flexible film circuit (18) providing an interconnection between a mother board (12) and a daughter board (14). Slidable cam means (22) are arranged to drive the flexible film circuitry against a face of the daughter board (14) after insertion and include keying means (40) arranged to register in apertures of the daughter board (14). A cam follower (24) is disposed between the cam means (22) and flexible film circuitry (18) which is inhibited against sliding movement with the cam by cooperating means (94, 34). Cooperating means acting between the cam (22) and follower (24) being adapted on movement of the follower (24) towards the daughter board (14) to effect a double wiping action between contact (10) of the flexible film circuitry (18) and complementary contacts on the daughter board.
Patent ES-550828-A0 (ES)
IPC: G01B21/20
Filed: 1986-01-13
Abstract: A dimensional checking tool for checking the 'flush' and 'gap' dimensions around a pressed panel has two probes 20 and 22 which move into and out of a housing 10, and are biassed in an outward direction, against the surfaces of a panel 34. Transducers or other devices 38 and 44 are sensitive to the positions of the probes and provide signals representative of the probe positions and which can be passed from the tool to an external data capture system.
Patent FI-822190-A0 (FI)
Inventor: MUTSERS STANISLAUS MARTINUS PE
IPC: C05C1/02
Filed: 1982-06-17
Abstract: Preparation of ammoniumnitrate-containing granules by granulating an ammoniumnitrate melt including 05.5-5% wt of a finely divided, insoluble, inert silica-containing material in a fluidized bed of ammoniumnitrate seed particles having a temperature between 95 und 145 DEG C. The granules obtained are thermally stable and have a low water content and a high bulk density.
Patent FI-842596-A0 (FI)
Inventor: YAMAMOTO HISAHIRO
IPC: A45D7/04
Filed: 1984-06-27
Abstract: PCT No. PCT/JP83/00381 Sec. 371 Date Jul. 17, 1984 Sec. 102(e) Date Jul. 17, 1984 PCT Filed Oct. 26, 1983 PCT Pub. No. WO84/01699 PCT Pub. Date May 10, 1984.A bundle of hair is clamped between a pair of corrugated curling members having alternate ridges and grooves at a predetermined pitch with a predetermined curvature, and then coated with a permanent waving solution to thereby form successive permanent waves on the hair bundle. The hair bundle clamped between the curling members is thereafter immersed in a neutralizing solution to neutralize the hair.
Patent FI-862370-A0 (FI)
Inventor: ROSENTHALER JOACHIM
IPC: C07K16/00
Filed: 1986-06-03
Abstract: Immunogenic conjugates comprising a carrier coupled to a cyclosporin having an activate coupling group, e.g. activated carboxy group, e.g. (i) [(O-succinimidooxysuccinyl)-Thr]<2>-Cyclosporine and (ii) [(N- epsilon -succinimidooxysuccinyl)-(D)Lys]<8>-Cyclosporine. The subject conjugates are useful for the generation of monoclonal antibodies capable of distinguishing between cyclosporins, e.g. Cyclosporine, and metabolites, e.g. Cyclosporins 17 and 18.
Patent FI-864216-A0 (FI)
Inventor: STENSTROEM LENNART
IPC: B65G21/06
Filed: 1986-10-17
Abstract: PCT No. PCT/SE86/00062 Sec. 371 Date Oct. 17, 1986 Sec. 102(e) Date Oct. 17, 1986 PCT Filed Feb. 14, 1986 PCT Pub. No. WO86/04787 PCT Pub. Date Aug. 28, 1986.A cassette to be used in a conveyor device for products, for instance food stuff. The cassette (18) comprises a thin, broad-sided and broken through casing of substantially uniform thickness having an openable cover of broken through type. The casing and cover are interconnected along one side of the cover in several joints (47) and are interconnectable at several locking locations (48) along an opposite side of the cassette such that the casing and cassette in spite of the broken through structure, form a rigid and strong unit when the cover is closed.
Patent FI-871900-A0 (FI)
Inventor: GIANNETTI ENZO
IPC: C08F14/18
Filed: 1987-04-29
Abstract: A process for polymerizing or copolymerizing fluorinated monomers, in an aqueous dispersion, by the use of radical starters and of fluorinated surfactants, characterized by working in the presence of a perfluoropolyether having neutral end groups, being liquid under the polymerization conditions and in the form of an aqueous emulsion, in order to increase the polymerization rate.
Patent FI-873719-A0 (FI)
Inventor: EMMERLING WINFRIED
IPC: C09J175/04
Filed: 1987-08-27
Abstract: Alkoxysilane-terminated, moisture-hardening polyurethanes obtained by reaction of OH-terminated diols and/or triols with diisocyanates to form NCO-terminated polyurethanes having an NCO functionality of at least 2, and reaction of some of the NCO groups with aliphatic alcohols to form a polyurethane having an NCO functionality of at least 1 and less than 2, or by reaction of the OH-terminated linear diols or triols with a mixture of mono- and diisocyanates to form NCO-terminated polyurethanes having an NCO functionality of at least 1 and less than 2, followed by a reaction of substantially all the free NCO functions of the polyurethanes obtained with aminoalkyl, mercaptoalkyl or epoxyalkyl alkoxysilanes. The polyurethanes thus obtained are particularly suitable as a basis for moisture-hardening one-component sealing compounds and adhesives.
Patent FI-884755-A0 (FI)
Inventor: GREGORY WALTER ADELMAN
IPC: C07D263/20
Filed: 1988-10-14
Abstract: Aminomethyl oxooxazolidinyl aroylbenzene derivatives, such as  l -N-[3-[4-(2,4-difluorobenzoyl)phenyl]-2-oxooxazolidin-5-ylmethyl]aceta mide, possess useful antibacterial activity.
Patent FI-890267-A0 (FI)
Inventor: JAGGI MATTHIAS
IPC: A47G27/04
Filed: 1989-01-18
Abstract: The seaming strip is an extruded profile and has between two longitudinal edges (1) an arched upper side (2) consisting of cylindrical segments (4) and a central flat portion (5). A groove (8) is moulded into the curved underside (3) adjacent to each longitudinal edge (1). For assembly, a pasty mass, e.g. silicon rubber, is packed into the two grooves (8) and the strip is pressed onto a joint between two floor coverings. Thus a simple assembly, a high degree of stepping safety and an improved sound-proofing are achieved. <IMAGE>
Patent FI-893961-A0 (FI)
Inventor: BIRKETT KEVIN LAWSON
IPC: C09K3/10
Filed: 1989-08-23
Abstract: A sealant or mastic composition comprises a dispersion of a finely divided particulate solid in a silicone resin formulation which contains a dispersant containing at least one group of the formula  - ( O - A - CO )n- The dispersant may be derived from a hydroxycarboxylic acid and preferably has a -COOH end group. The dispersant modifies the shear properties of the sealant.
Patent FI-901650-A0 (FI)
Inventor: LYSEN CLAES G
IPC: G01F23/18
Filed: 1990-04-02
Abstract: A solids level detecting assembly (11) is particularly useful for detecting the level of paper pulp (or wood chips during the manufacture of pulp) in a vertical vessel (10) . A first hollow shaft (12) is affixed at a portion thereof to a vessel with a first end (13) extending into the vessel. A second shaft (20), concentric with the first, is disposed within it and connected at a first end (23) thereof to the first end of the hollow shaft, and to a paddle (plate) (22). A sensing device, including a movable core element (28) of high magnetic permeability material, is mounted to a free end (24, 40) of the second shaft. A stationary core element (43) is mounted adjacent the movable element so that a twisting motion of the first shaft as a result of solid particles acting on the plate changes the flux in the core elements. A flux detector (comprising a pair of coils (70, 71) and a voltage detector (76)) detects the changes in magnetic flux in the core elements, and indicates the change on an indicator (77), which thus illustrates the level of pulp or chips within the vessel.
Patent FI-912511-A0 (FI)
Inventor: HOLMSTEDT JAN WALTER
IPC: C04B28/26
Filed: 1991-05-23
Abstract: The invention provides a method of treating fibrous cellulosic web for manufacture of corrugated or laminated sheets, tubes (10, 20) or other elements suitable for use in the building industry or for packing. The web (5) of material passes continuously through 3 separate chambers (1, 2, 3) before entering forming apparatus. The first chamber (1) contains a liquid for breaking down the fibres of the web (5); the second chamber (2) contains a liquid for impregnating the fibrous cellulosic web; and the third chamber (3) contains a liquid for enhancing the elasticity of the impregnated fibrous cellulosic web and for reducing the drying time of the web (5). During the forming of a corrugated product, a glue comprising an alkali metal silicate solution, an acetone solution and a hardener e.g. triacetin is used. The sheets (10) or tubes (20) or other elements formed in the forming process are then sprayed with a liquid for enhancing the resistance to water of the fibrous cellulosic web. The liquids can be used advantageously in other processes.
Patent FI-921233-A0 (FI)
Inventor: RISTELI JUHA
IPC: G01N33/577
Filed: 1992-03-20
Abstract: An antibody raised to type I collagen carboxyterminal cross-linked telopeptide isolated from decalcified human or animal bone, may be used in an assay to determine the concentration of liberated carboxyterminal telopeptide region of the type I collagen molecule in a sample. When the sample is a body fluid such as serum or urine the degradation product measured is resistant to further degradation, since it contains a multivalent intermolecular cross-link, and can thus be found in the body fluid. The assay may be used to assess the degradation of type I collagen, the major organic constituent of bone matrix.
Patent FI-945151-A0 (FI)
Inventor: HUOTARI SEPPO
IPC: H04M3/00
Filed: 1994-11-01
Abstract: PCT No. PCT/FI95/00601 Sec. 371 Date Aug. 22, 1997 Sec. 102(e) Date Aug. 22, 1997 PCT Filed Oct. 31, 1995 PCT Pub. No. WO96/13949 PCT Pub. Date May 9, 1996The invention relates to a mobile communication network and a method for activating intelligent network services in the mobile communication network. In the invention, the mobile services switching center (MSC) operates as the service switching point of the intelligent network. The mobile services switching center stores the service triggers, which service triggers comprise the triggering criteria for the services and the information required for visiting the service control point (SCP). The mobile subscriber's subscriber data in the subscriber database (HLR) is provided with an intelligent network service trigger key which points to one or more service triggers. As the mobile services switching center obtains the trigger key of the mobile subscriber during the call setup, it activates the service triggers indicated by the key. As the triggering criteria of the service trigger are met at some phase of the call, the mobile services switching center triggers the respective intelligent network service in the service control point (SCP) indicated by the service trigger.
Patent FI-964317-A0 (FI)
Inventor: AL-OBEIDI FAHAD
IPC: C07K5/09
Filed: 1996-10-25
Abstract: The invention provides compounds which specifically inhibit factor Xa activity. The compounds consist of the structure X 1 -YIR-X 2 , wherein X 1  is H, acyl, alkyl, acylalkyl, arylalkyl or one or more amino acids, and X 2  is a modified C-terminal group, one or more carboxy-protecting groups or one or more amino acids or other substituent, and Y, I and R are tyrosine, isoleucine and arginine, respectively, or peptidomimetic or organic structures that possess the same functional activity as Y, I and R, respectively. In addition, the present invention provides a compound having the structure A1-A2-(A3) m -B, where m is 0 or 1. A compound of the invention can be linear or cyclic and can be about 2 and 43 residues in length. A compound of the invention is characterized, in part, in that it exhibits a specific inhibition of factor Xa activity with a K i  of ¤ 100 µM, preferably ¤ 2 nM, and does not substantially inhibit the activity of other proteases involved in the coagulation cascade. The invention further provides methods of specifically inhibiting the activity of factor Xa and of inhibiting blood clotting in  vitro  and in an individual and methods of detecting factor Xa levels or activity.
Patent FI-973517-A0 (FI)
Inventor: DEL DUCA VALERIO
IPC: C11D1/83
Filed: 1997-08-27
Abstract: The present invention relates to the use of a liquid composition comprising a peroxygen bleach and a compound chelating copper and/or iron and/or manganese, for pretreating fabrics before said fabrics are washed, whereby the loss of tensile strength in said fabrics is reduced. The present invention further encompasses a process for pretreating soiled fabrics as well as compositions suitable to be used in said process.
Patent AP-9801253-A0 (AP)
Title: 9-Oxime erythromycin derivatives.
Inventor: WU YONG-JIN
IPC: A61P31/04
Filed: 1998-06-04
Abstract: The invention related to compounds of the formula i and to pharmaceutically acceptable salts thereof, wherein r1, r2, r6 and x are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula i, methods of using said compounds of formula i in the treatment of bacterial protozoa infections, and methods of preparing said compounds of formula i.
Patent IL-86705-A0 (IL)
Title: Fluid flow metering apparatus
IPC: G01F3/20
Filed: 1988-06-10
Abstract: A fluid flow meter comprising a housing having a pair of fluid ports and defining therebetween a fluid flow path; a flexible membrane defining a pair of opposing faces and being mounted in the fluid flow path such that the pair of faces simultaneously define with the housing fluid impermeable seals at at least two different locations along the flow path, the membrane being operative to flex so as to permit passage therepast of discrete quanta of fluid, each having a known volume; apparatus for generating electrical signals corresponding to flexure of the membrane; and monitoring apparatus for receiving the electrical signals and thereby determining a fluid flow rate along the flow path.
Patent IL-98184-A0 (IL)
Title: 3-(1-thiazololidinylbutyl-4-piperazinyl-1h-indazoles,a process for their preparation and their use as medicaments
IPC: C07D417/12
Filed: 1991-05-17
Abstract: This invention relates to 3-[1-thiazolidinylbutyl-4-piperazinyl]-1H-indazoles of the formula I <CHEM> where R1 and R2 are each independently hydrogen or loweralkyl or R1 and R2 taken together with the carbon atom to which they are attached form a cyclopentane, cyclohexane or cycloheptane ring; R3 ad R4 are independently hydrogen or loweralkyl or R3 and R4 taken together with the carbon atom to which they are attached form a cyclopentane, cyclohexane or cycloheptane ring; R5 is hydrogen, loweralkyl, alkanoyl or aroyl; X is halogen, loweralkyl or alkoxy; m is an integer of 0 to 3, the pharmaceutically acceptable acid addition salts thereof and where applicable, the optical, geometrical and stereoisomers and racemic mixtures thereof. The compounds of this invention are useful as antipsychotic agents.
Patent IL-98605-A0 (IL)
Title: Process for making low optical density polymers and copolymers for photoresists and optical applications
IPC: C08F2/00
Filed: 1991-06-24
Abstract: Polymers comprising poly(4-hydroxystyrene) and/or substituted poly(4-hydroxystyrene) are produced by polymerizing 4-acetoxystyrene and/or substituted 4-acetoxystyrene monomers, with or without other comonomers, and subsequently performing transesterification. Preferably, the polymers are produced using at least one alcohol as a reaction medium, a chain transfer agent and a transesterification reactant. It is appropriate: to use an initiator which does not comprise a substantially absorbant structure over the 240 to 260 nm range or to use an initiator concentration of less than about 3 mole % of the monomer(s); to obtain a polymerization conversion of the initial polymerization monomers of at least about 90% by weight, or to remove residual monomer(s) from the reaction medium prior to transesterification; to obtain a transesterification conversion of the polymerized monomers of at least 85% by weight; and to avoid the use of transesterification catalysts which can cause the formation of chemical structures which can absorb over the 240 to 260 nm radiation wavelength range. The target polymers have low optical density (absorbance) over a wavelength range from 240 to 260 nm, as well as low optical density over the near UV and visible spectrum (310 to 800 nm); and are useful as photoresist components for use in combination with deep UV, X-ray, and E-Beam imaging systems.
Patent IL-98991-A0 (IL)
Title: Derivatives of benzofuran,benzothiophene,indole and indolizine,their preparation and pharmaceutical compositions containing them
IPC: C07D221/00
Filed: 1991-07-29
Abstract: Heterocycles of formula (I) and their pharmaceutically acceptable salts are new. Het = gp. (i)-(iii), T = RRaN, R and Ra = H, 1-4C alkyl or SO2R1, R1 = 1-6C alkyl, CF3, phenyl, benzyl or benzoyl (all opt. substd.) or Ra and R1 together form a 3-6C cyclic sulphonamide, T' = H, NO2 or RRaN, T'' = benzyloxycarbonyl, T''1-OCO, T''2, T''3N.CO or NRRa, T''1, T''2 and T''3 = H or 1-4C alkyl or T''2 and T''3 together complete a 4-6C ring, X = O or S, Y = CO, CHOR5 or CH2, R5 = H, 1-4C alkyl or COR'4, R'4 = 1-4C alkyl, R1 = 1-6C alkyl or phenyl (opt. substd.), R2 = H or 1-6C alkyl, R3 =- 1-6C alkyl or R6-alk, or R2 and R3 are together a 3-6C alkylene or alkenylene (opt. substd.) and opt. interrupted by O, NH, N= or NR7, alk = bond or 1-5C alkylene, R6 = pyridyl, phenyl, phenoxy (the last 2 opt. substd. by 1 or more of halo or 1-4C alkyl or alkoxy) or 3,4-methylene dioxyphenyl, R7 = 1-4C alkyl or phenyl, R4 = H, 1-4C alkyl, R'1SO2 or R74R''4N-(CH2)m, R'1 = 1-4C alkyl, phenyl or benzyl (both opt. substd.), R'4 and R''4 = 1-4C alkyl, m = 1-3, A = O, S or NHCO. When W and W' are each =CH- or N, Z = O or S but when W = =CH-and W' = =CR8-, Z = -CH=CR'8-, R8 and R'8 = H, halo or 1-4C alkyl or alkoxy, n = 1-5 provided than when R4 = SO2R'1, T' is H, NO2 or cyclised RRaN. 5 Cpds. are specifically claimed, including 2-(n-butyl)-3-(4-(3-di-n-butylamino -propoxy) benzoyl)-5-methylsulphonamido -benzofuran.
Patent FI-20000418-A0 (FI)
Inventor: HAUTALA ARTO
IPC: A61B5/22
Filed: 2000-02-23
Abstract: A heart rate measuring arrangement comprising measuring means (410A-410B) for measuring the heart rate, forming means (452) for forming control information from the heart rate information obtained by measuring to control a recovery exercise, display means (450) for presenting the formed control information. <IMAGE>
Patent IL-111134-A0 (IL)
Title: Immunological tolerance-inducing agent
IPC: A61K39/385
Filed: 1994-10-03
Abstract: An immunological tolerance-inducing agent comprising a mucosa-binding molecule linked to a specific tolerogen is disclosed. Further, a method of inducing immunological tolerance in an individual against a specific antigen, including hapten, which causes an unwanted immune response in said individual comprising administration by a mucosal route of an immunologically effective amount of an immunological tolerance-inducing agent of the invention to said individual, is described.
Patent IL-116521-A0 (IL)
Title: Process for the production of divisible tablets
IPC: B30B11/16
Filed: 1995-12-22
Abstract: PCT No. PCT/EP95/05117 Sec. 371 Date Jun. 18, 1997 Sec. 102(e) Date Jun. 18, 1997 PCT Filed Dec. 22, 1995 PCT Pub. No. WO96/19962 PCT Pub. Date Jul. 4, 1996A process for the production of divisible tablets by melt calendering in which two molding rolls are combined together, at least one of which has depressions with at least one bar which extends up to the surface line of the molding roll and forms a score.
Patent IL-125027-A0 (IL)
Title: 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin d methods for their production and pharmaceutical compositions thereof
IPC: A61P37/00
Filed: 1996-12-23
Abstract: 1-Hydroxy pregnacalciferol derivatives of formula (I) and their corresponding 5,6-trans isomers wherein R1 is hydroxyl or lower alkoxy and R2 is optionally hydroxylated or lower alkoxylated lower alkynyl or R1 is C(RA) (RB)CH3 where RA is optionally hydroxylated or lower alkoxylated lower alkynyl and RB is hydroxyl or lower alkoxy or RA and RB together represent oxo and R2 is hydrogen, hydroxyl or lower alkoxy, and R3 and R4 represent hydrogen atoms, exhibit anti-progesterone activity and may be useful as antineoplastic, antifertility, antiproliferative, immunosuppressive and/or antiinflammatory agents.
Patent IL-129568-A0 (IL)
Title: Compositions for reducing odor on skin
IPC: A61K8/891
Filed: 1997-10-23
Abstract: The present invention relates to an aqueous odor-absorbing composition which is safe for use on human skin comprising from about 0.1 % to about 5 %, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from about 0.5 % to about 30 %, by weight of the composition, of a linear dimethicone having a nominal viscosity of 350 centistokes or less; and an aqueous carrier. The compositions can also comprise one or more of the following optional components: low molecular weight polyols; water-soluble antimicrobial preservatives; zinc salts; water-soluble polymers; soluble carbonate and/or bicarbonate salts; chelating agents; zeolites; activated carbon; and mixtures thereof. The present invention also relates the use of the aforementioned compositions in reducing body, vaginal, and or environmental odors on skin. The composition can be applied directly as a spray, poured from a bottle and applied by hand, or applied via a wipe.
Patent IL-136689-A0 (IL)
Title: Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists
IPC: A61K31/4433
Filed: 1998-12-16
Abstract: This invention is related to novel carboxyl substituted chroman derivatives which are useful in the treatment of beta-3 receptor mediated conditions.
Patent IL-143889-A0 (IL)
Title: Computer with illuminator for keyboard
IPC: G06F/
Filed: 2000-07-03
Abstract: IN A PORTABLE COMPUTER (100), AN LED HOLDER (150) IS PROVIDED IN THE UPPER PORTION OF AN LCD (109) AND AN LED IS ATTACHED INSIDE THE LED HOLDER (150). LIGHT EMITTED FROM THE LED PASSES THROUGH AN APERTURE PROVIDED IN THE BOTTOM PORTION OF THE LED HOLDER (150) AND ILLUMINATES A KEYBOARD (1 03).(FIG 3)